Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Cellular Biomedicine Opens Beijing Facility

publication date: Nov 10, 2015
Cellular Biomedicine, a China-US cell therapy company, officially opened a GMP manufacturing facility in the PKUCare Industrial Park of Beijing. CBMG is developing stem cell products for joint and autoimmune disorders, and earlier this year, the company in-licensed CAR-T immuno-oncology technology from the Chinese PLA General Hospital (the 301 hospital) of Beijing. CBMG is headquartered in Cupertino, California, but China is its primary market. The new facility in Beijing adds capacity to CBMG's existing plants in WuXi and Shanghai. More details....

Stock Symbol: (NSDQ: CBMG)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital